Clinical Updates for Gastrointestinal Malignancies

Dear Colleagues,

Gastrointestinal (GI) cancers encompass malignancies that can affect several organs of the digestive tract: the pancreas, stomach, liver, small and large intestines, colon, rectum, anus, and the biliary system. Notably, colorectal cancer and gastric cancer are the third and fifth most frequent types of cancer, respectively and are amongst the fifth most common causes of cancer-related death worldwide. The treatment options for GI cancers depend on the tumor type and stage, and may include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. In particular, recently, there have been notable advancements in the development of innovative treatments for GI cancers, such as targeted therapy and immunotherapy.

The main objective of this Special Issue is to provide a comprehensive overview of the current advancements in diagnostic and therapeutic strategies, and a better prognostic stratification for GI cancers with the goal of advancing knowledge and improving patient outcomes.

In this Special Issue, original research articles and reviews are welcome.

I look forward to receiving your contributions.

Dr. Carmelo Laface
Dr. Riccardo Memeo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gastrointestinal cancers
• tumor microenvironment
• targeted therapy
• immunotherapy
• total neoadjuvant therapy
• surgical oncology
• complications
• diagnosis